# The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients

> **NCT00351663** · PHASE4 · COMPLETED · sponsor: **Shaare Zedek Medical Center** · enrollment: 39 (actual)

## Conditions studied

- Venous Thrombosis
- Critical Illness

## Interventions

- **DRUG:** Enoxaparine

## Key facts

- **NCT ID:** NCT00351663
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2014-04
- **Final completion:** 2015-09
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2016-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351663, "The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT00351663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*